Thanks Mo, those are excellent highlights from tod

Thanks Mo, those are excellent highlights from today's shareholder alert. And yes, the international community is increasingly aware of Brilacidin.

The "Mab" and "Vir" drugs will be no match for Brilacidin if in vitro results are anywhere near approximated in the 100% enrolled PH 2 clinical trial.

Leo is smart not to PR that shareholder alert. He's playing by the FDA rules and is wise as to what happened to CYDY with their premature promo.

I suspect the stock price will start to be pressured slowly upward sooner than later, in anticipation of results coming in August.